1. Home
  2. IMNM vs NSA Comparison

IMNM vs NSA Comparison

Compare IMNM & NSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$22.12

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo National Storage Affiliates Trust of Beneficial Interest

NSA

National Storage Affiliates Trust of Beneficial Interest

HOLD

Current Price

$44.57

Market Cap

2.9B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
NSA
Founded
2006
2013
Country
United States
United States
Employees
N/A
1458
Industry
Medicinal Chemicals and Botanical Products
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
IMNM
NSA
Price
$22.12
$44.57
Analyst Decision
Strong Buy
Hold
Analyst Count
10
9
Target Price
$32.80
$34.38
AVG Volume (30 Days)
1.7M
784.6K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
5.50%
EPS Growth
51.40
N/A
EPS
N/A
N/A
Revenue
$6,941,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,127.34
$2.39
P/E Ratio
N/A
$56.31
Revenue Growth
N/A
N/A
52 Week Low
$8.67
$27.43
52 Week High
$27.65
$46.47

Technical Indicators

Market Signals
Indicator
IMNM
NSA
Relative Strength Index (RSI) 52.69 49.93
Support Level $19.28 $43.50
Resistance Level $23.25 $46.36
Average True Range (ATR) 1.36 1.01
MACD -0.03 -0.14
Stochastic Oscillator 45.98 28.94

Price Performance

Historical Comparison
IMNM
NSA

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About NSA National Storage Affiliates Trust of Beneficial Interest

National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.

Share on Social Networks: